PARAMETRIC PORTFOLIO ASSOCIATES LLC - ENDOLOGIX INC ownership

ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 123 filers reported holding ENDOLOGIX INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of ENDOLOGIX INC
ValueSharesWeighting
Q4 2018$132,000
-65.9%
183,818
-9.2%
0.00%
Q3 2018$387,000
-62.1%
202,537
+12.4%
0.00%
-100.0%
Q2 2018$1,020,000
+38.8%
180,189
+3.7%
0.00%0.0%
Q1 2018$735,000
-19.6%
173,813
+1.7%
0.00%0.0%
Q4 2017$914,000
+57.6%
170,868
+31.5%
0.00%0.0%
Q3 2017$580,000
+51.0%
129,945
+64.5%
0.00%
Q2 2017$384,000
-40.9%
78,975
-12.0%
0.00%
-100.0%
Q1 2017$650,000
+64.6%
89,748
+30.0%
0.00%0.0%
Q4 2016$395,000
-55.0%
69,063
+0.8%
0.00%0.0%
Q3 2016$877,000
-20.1%
68,529
-22.2%
0.00%
-50.0%
Q2 2016$1,098,000
+131.6%
88,108
+55.5%
0.00%
+100.0%
Q1 2016$474,000
+159.0%
56,673
+207.2%
0.00%
Q4 2015$183,000
-57.0%
18,448
-46.9%
0.00%
-100.0%
Q3 2015$426,000
-23.1%
34,719
-3.8%
0.00%0.0%
Q2 2015$554,000
-16.8%
36,107
-7.4%
0.00%0.0%
Q1 2015$666,000
+16.0%
39,002
+3.9%
0.00%0.0%
Q4 2014$574,000
+89.4%
37,554
+31.6%
0.00%0.0%
Q3 2014$303,000
-32.2%
28,543
-2.9%
0.00%0.0%
Q2 2014$447,000
+11.5%
29,392
-5.6%
0.00%0.0%
Q1 2014$401,000
-23.9%
31,139
+3.0%
0.00%0.0%
Q4 2013$527,000
+16.6%
30,231
+8.0%
0.00%0.0%
Q3 2013$452,000
+34.9%
27,996
+11.1%
0.00%0.0%
Q2 2013$335,00025,2090.00%
Other shareholders
ENDOLOGIX INC shareholders Q4 2014
NameSharesValueWeighting ↓
Tamarack Capital Management, LLC 4,050,000$49,653,0005.91%
Essex Woodlands Management, Inc. 1,257,468$21,220,0003.88%
PURA VIDA INVESTMENTS, LLC 205,100$2,515,0001.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,347,113$28,776,0001.11%
First Light Asset Management, LLC 180,963$2,219,0001.10%
ArrowMark Colorado Holdings LLC 2,889,546$35,426,0000.97%
PALISADE CAPITAL MANAGEMENT, LP 2,149,949$26,358,0000.78%
Iguana Healthcare Management, LLC 150,000$1,839,0000.72%
CADIAN CAPITAL MANAGEMENT, LP 1,492,443$18,297,0000.66%
WASHINGTON CAPITAL MANAGEMENT, INC 85,882$1,053,0000.66%
View complete list of ENDOLOGIX INC shareholders